False positive carbohydrate antigen 19-9 (CA19-9) results due to a low-molecular weight interference in an apparently healthy male

Clinica Chimica Acta

Volumn 406, Issue 1-2, 2009, Pages 41-44

  Monaghan, P J ^a   Leonard, M B ^a   Neithercut, W D ^a   Raraty, M G T ^b   Sodi, R ^b  

^a WIRRAL UNIVERSITY TEACHING HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

CA19 9; Carbohydrate antigen; False positive; Interference; Pancreatic cancer

Indexed keywords

ALPHA FETOPROTEIN; ATORVASTATIN; C REACTIVE PROTEIN; CA 19-9 ANTIGEN; LECTIN; MACROGOL; SERTRALINE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DIAGNOSTIC ERROR; DIARRHEA; DIET THERAPY; DILUTION; DIVERTICULOSIS; DYSPEPSIA; ENDOSCOPIC ECHOGRAPHY; FALSE POSITIVE RESULT; FATIGUE; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOASSAY; INCUBATION TIME; INTERMETHOD COMPARISON; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MOLECULAR WEIGHT; PANCREAS CANCER; PATIENT REFERRAL; PRECIPITATION; PRIORITY JOURNAL; REFERENCE VALUE;

ANIMALS; ARTIFACTS; CA-19-9 ANTIGEN; CHROMATOGRAPHY, GEL; FALSE POSITIVE REACTIONS; HEALTH; HUMANS; IMMUNOASSAY; LECTINS; MALE; MICE; MIDDLE AGED; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; PRECIPITATION; REFERENCE VALUES;

ANIMALIA;

EID: 67650217532     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.05.012     Document Type: Article

References (18)

1. Ismail A.A., Walker P.L., Barth J.H., Lewandowski K.C., Jones R., and Burr W.A. Wrong biochemistry results: two case reports and observational study on 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotrophin immunoassay results. Clin Chem 48 (2002) 2023-2029
2. Ismail A.A. On the interpretation of affirmative follow-up tests in immunoassay: what must not be done?. Ann Clin Biochem 43 (2006) 249-251
3. Kricka L.J. Interferences in immunoassay: still a threat. Clin Chem 46 (2000) 1037-1038
4. Vestergaard E.M., Hein H.O., Meyer H., et al. Reference values and biological variation for tumour marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. Clin Chem 45 (1999) 54-61
5. Koprowski H., Steplewski Z., Mirchel K., Herlyn M., Herlyn D., and Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5 (1979) 957-971
6. Farini R., Fabris C., Bonvicini P., et al. CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis. Eur J Cancer Clin Oncol 21 (1985) 429-432
7. Dietel M., Arps H., Klapdor R., Muller-Hagen S., Sieck M., and Hoffman L. Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera. J Cancer Res Clin Oncol 111 (1986) 257-265
8. Duraker N., Hot S., Polat Y., Hobek A., Gencler N., and Urhan N. CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. J Surg Oncol 95 (2007) 142-147
9. Immunoassay interference by endogenous antibodies. Proposed Guideline. CLSI document I/LA30-P: Clinical and Laboratory Standards Institute, 2007.
10. Kellogg M.D., Law T.C., Huang S., and Rifai N. A girl with goitre and inappropriate thyroid-stimulating hormone secretion. Clin Chem 54 (2008) 1241-1245
11. Ismail A.A. On detecting interference from endogenous antibodies in immunoassays by doubling dilutions test. Clin Chem Lab Med 45 (2007) 851-854
12. Levinson S.S., and Miller J.J. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 325 (2002) 1-15
13. Fahie-Wilson M., and Halsall D. Polyethylene glycol precipitation: proceed with care. Ann Clin Biochem 45 (2008) 233-235
14. Venegas M., Liu L., Lovell L., et al. Purification and immunochemical characterisation of ascitic fluid glycoproteins containing certain tumour-associated and blood group antigen markers. Glycoconj J 6 (1989) 511-524
15. Berth M., Bosmans E., Everaert J., et al. Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9). Clin Chem Lab Med 44 (2006) 1137-1139
16. Biguet B., Habersetzer F., Beaudonnet A., Bizollon C.A., Trepo C., and Cohen R. Discordant CA 19-9 serum results by microparticle enzyme immunoassay and immunoradiometric assay. Clin Chem 41 (1995) 1057-1058
17. Miura H., Kitano M., Yoneyama A., Kuwahara A., Moriyama K., and Kitajima S. IgG heterophile antibody causes false positivity for CA19-9, which is overcome with bovine immunoglobulin. Rinsho Byori 53 (2005) 1103-1108
18. Liang Y., Yang Z., Ye W., Yang J., He M., and Zhong R. Falsely elevated carbohydrate antigen 19-9 level due to heterophilic antibody interference but not rheumatoid factor: a case report. Clin Chem Lab Med 47 (2009) 116-117